CATHERINE HASSETT: Open Payments
NPI 1689151821 · LONGMEADOW, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 22 payments from 8 companies in 2025. Trend: 2023 $449 · 2024 $1,146 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $165 |
| ABBVIE INC. | 2 | $115 |
| COLOPLAST CORP | 6 | $111 |
| Antares Pharma, Inc. | 1 | $30 |
| 180 Medical, Inc. | 1 | $28 |
| Endo USA, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| UROGEN PHARMA, INC. | 1 | $21 |
Products named: BOTOX, Luja Coude, ORGOVYX, GEMTESA, XYOSTED, GENTLECATH, AVEED, ADSTILADRIN.
Industry payments across MA — which companies pay providers there.
